Welcome to the L.B. Bohle Maschinen + Verfahren GmbH press center.
Update information about the company is available here; you may also download files and browse through the archives.

Please do not hesitate to contact us should you require further information or would like to make an appointment for an interview or inquiries about the company.

Your contact at the company:

Tobias Borgers
Marketing / Public Relations

An integral element to the L.B. Bohle success story for almost 30 years

The company’s history began with a blender in 1987 – in the meantime, L.B. Bohle, the machine builder from Ennigerloh, has manufactured more than 3,000 blenders. Day by day, the most varied blending systems are used in the production lines of pharmaceutical companies and toll manufacturers worldwide.
Thanks to the innovative design, flexibility and a long service life of the machines, L.B. Bohle has become the world market leader in the area of blenders.

Sales Office relocates from Goa to the metropolis of Mumbai
The pharmaceutical industry in India is one of the fastest growing sectors of the emerging country. 70 percent of all generics are produced on the sub-continent. Between 2011 and 2016 alone, the turnover generated by the pharmaceutical industry will more than double, from USD 14 billion to about USD 34 billion, according to the German Statistics Office.

Reasons enough for L.B. Bohle to keep a firm eye on this growth market and to assess the market opportunities for its own high tech machines. With the sale and commissioning of a BFC 600 Film Coater, the specialists for solids production now have established an important reference for this future market.

L.B. Bohle increases turnover to EUR 48 million – Pharmaceutical industry makes use of Technology Center
Investments in Innovation Laid the Foundation for a Growth Spurt in 2015 The investments in the future have paid off for L.B. Bohle Maschinen + Verfahren GmbH in the 2015 business year: The special machine builder for the pharmaceutical industry increased its turnover by 26 per- cent to EUR 48 million. CEO Lorenz Bohle lists the success stories: “We have won a prestigious contract from a global leader in the US, despite strong competition. In Russia alone, we generated EUR 6 million. And we have several major projects running in South America and Mexico.” For 2016, he forecasts “a growth rate between ten and 15 percent”.

Continuous ManufacturingStart Your Continuous Manufacturing with QbCon

Continuous Manufacturing

From Powder to the coated tablet: The unique feature of the production unit QbCon® is that the tablet production can be implemented either without granulation or with dry or wet granulation, in one system.

Test QbCon® Now

Complete Solid Dosage ProductionTest Our Machines in the Service Center

Solid dosage production

The Bohle Service Center enables the presentation and testing from our machines as well as the executions of workshops and tutorials.

to Service Center